Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CILGAVIMAB\TIXAGEVIMAB Cause Drug ineffective? 123 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 123 reports of Drug ineffective have been filed in association with CILGAVIMAB\TIXAGEVIMAB. This represents 5.7% of all adverse event reports for CILGAVIMAB\TIXAGEVIMAB.

123
Reports of Drug ineffective with CILGAVIMAB\TIXAGEVIMAB
5.7%
of all CILGAVIMAB\TIXAGEVIMAB reports
16
Deaths
75
Hospitalizations

How Dangerous Is Drug ineffective From CILGAVIMAB\TIXAGEVIMAB?

Of the 123 reports, 16 (13.0%) resulted in death, 75 (61.0%) required hospitalization, and 3 (2.4%) were considered life-threatening.

Is Drug ineffective Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CILGAVIMAB\TIXAGEVIMAB. However, 123 reports have been filed with the FAERS database.

What Other Side Effects Does CILGAVIMAB\TIXAGEVIMAB Cause?

Covid-19 (521) Product use issue (94) Fatigue (86) Headache (86) Dyspnoea (84) Pyrexia (81) Nausea (68) Dizziness (64) Breakthrough covid-19 (51) Pneumonia (49)

What Other Drugs Cause Drug ineffective?

ADALIMUMAB (71,926) METHOTREXATE (70,142) ETANERCEPT (60,367) ADAPALENE (52,181) ABATACEPT (35,212) INFLIXIMAB (33,738) TOCILIZUMAB (32,342) RITUXIMAB (32,186) LEFLUNOMIDE (31,396) HYDROXYCHLOROQUINE (31,057)

Which CILGAVIMAB\TIXAGEVIMAB Alternatives Have Lower Drug ineffective Risk?

CILGAVIMAB\TIXAGEVIMAB vs CILOSTAZOL CILGAVIMAB\TIXAGEVIMAB vs CILTACABTAGENE AUTOLEUCEL CILGAVIMAB\TIXAGEVIMAB vs CIMETIDINE CILGAVIMAB\TIXAGEVIMAB vs CIMZIA CILGAVIMAB\TIXAGEVIMAB vs CINACALCET

Related Pages

CILGAVIMAB\TIXAGEVIMAB Full Profile All Drug ineffective Reports All Drugs Causing Drug ineffective CILGAVIMAB\TIXAGEVIMAB Demographics